[HTML][HTML] A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors

X Qian, Z Shi, H Qi, M Zhao, K Huang, D Han… - Theranostics, 2019 - ncbi.nlm.nih.gov
Cell-based immunotherapy for the treatment of hematologic malignancies, such as leukemia
and lymphoma, has seen much success and played an increasingly important role in clinical …

Dynamic colocalization microscopy to characterize intracellular trafficking of nanomedicines

D Vercauteren, H Deschout, K Remaut… - ACS …, 2011 - ACS Publications
To gain a better understanding of intracellular processing of nanomedicines, we employed
quantitative live-cell fluorescence colocalization microscopy to study endosomal trafficking …

Measuring the intravitreal mobility of nanomedicines with single-particle tracking microscopy

TF Martens, D Vercauteren, K Forier, H Deschout… - …, 2013 - Future Medicine
Aim: To develop a robust assay to evaluate and compare the intravitreal mobility of
nanoparticles in the intact vitreous body. Materials & methods: Excised bovine eyes were …

Cellular uptake pathways of nanoparticles: process of endocytosis and factors affecting their fate

S Varma, S Dey, D Palanisamy - Current Pharmaceutical …, 2022 - ingentaconnect.com
Background: Efficient and controlled internalization of NPs into the cells depends on their
physicochemical properties and dynamics of the plasma membrane. NPs-cell interaction is a …

Glycosaminoglycans in the cellular uptake of drug delivery vectors–bystanders or active players?

ME Favretto, R Wallbrecher, S Schmidt… - Journal of controlled …, 2014 - Elsevier
The implementation of efficient strategies for cellular delivery is the most significant hurdle in
the development of oligonucleotide and protein-based nanomedicines. Unlike small …

Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges

L Xu, Y Cao, Y Xu, R Li, X Xu - Macromolecular Bioscience, 2024 - Wiley Online Library
Cancer development and progression of cancer are closely associated with the activation of
oncogenes and loss of tumor suppressor genes. Nucleic acid drugs (eg, siRNA, mRNA, and …

siRNA transfection with calcium phosphate nanoparticles stabilized with PEGylated chelators

EV Giger, B Castagner, J Räikkönen… - Advanced …, 2013 - Wiley Online Library
Despite the enormous therapeutic potential of siRNAs, their delivery is still problematic due
to unfavorable biodistribution profiles and poor intracellular bioavailability. Calcium …

Novel polyethyleneimine-R8-heparin nanogel for high-efficiency gene delivery in vitro and in vivo

L Song, X Liang, S Yang, N Wang, T He, Y Wang… - Drug Delivery, 2018 - Taylor & Francis
Gene therapy is an efficient and promising approach to treat malignant tumors. However,
protecting the nucleic acid from degradation in vivo and efficient delivering it into tumor cells …

Nonviral gene delivery vectors use syndecan-dependent transport mechanisms in filopodia to reach the cell surface

ZU Rehman, KA Sjollema, J Kuipers, D Hoekstra… - ACS …, 2012 - ACS Publications
Lipoplexes and polyplexes, that is, assemblies of cationic lipids and polymers with nucleic
acids, respectively, are popular nanocarriers for delivery of genes or siRNA into cells for …

Bioreducible, hydrolytically degradable and targeting polymers for gene delivery

I Ullah, K Muhammad, M Akpanyung… - Journal of materials …, 2017 - pubs.rsc.org
Recently, synthetic gene carriers have been intensively developed owing to their promising
application in gene therapy and considered as a suitable alternative to viral vectors because …